热门资讯> 正文
Ekso Bionics展示了外骨骼设备的AI集成突破
2025-06-18 20:12
- Ekso Bionics (NASDAQ:EKSO) on Wednesday said that it has successfully demonstrated initial proof-of-concept in integrating artificial intelligence-enabled capabilities across its portfolio of enterprise health and personal health exoskeleton devices.
- The first of these capabilities is a new AI voice agent designed for intelligent control of the company’s legacy EksoNR device.
- Ekso Voice Agent is being implemented on NVIDIA (NVDA) Jetson Orin Nano hardware developed with the NVIDIA JetPack SDK and OpenAI tools for voice recognition.
- The proof-of-concept is configured as an Edge AI system, which can run with or without a connection to the cloud.
More on Ekso Bionics Holdings
- Ekso Bionics Holdings, Inc. (EKSO) Q1 2025 Earnings Call Transcript
- Ekso Bionics announces 1-for-15 reverse stock split
- Ekso bionics anticipates scaling personal health revenues in 2025 with new partnerships
- Seeking Alpha’s Quant Rating on Ekso Bionics Holdings
- Historical earnings data for Ekso Bionics Holdings
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
